InsiderTrades

Form 4 for AMD Advanced Micro Devices

Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-19 · accession 0000002488-25-000171 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-21 2025-11-19 AMD Norrod Forrest Eugene EVP, GM DESG M - OptEx $34.19 +8,200 319.8K +3% +$280.4K
DM 2025-11-21 2025-11-19 AMD Norrod Forrest Eugene EVP, GM DESG S - Sale+OE $229.37 -19.4K 300.3K -6% -$4.46M
D 2025-11-21 2025-11-19 AMD Norrod Forrest Eugene EVP, GM DESG M - OptEx $0.00 -8,200 16.4K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-19 M A 8,200 $34.19 319,798 D — — (F1) The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
2 Common Common Stock 2025-11-19 S D 3,300 $228.36 316,498 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F3) Transaction executed in multiple trades at prices ranging from $227.66 to $228.65 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3 Common Common Stock 2025-11-19 S D 10,188 $229.21 306,310 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F4) Transaction executed in multiple trades at prices ranging from $228.68 to $229.67 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
4 Common Common Stock 2025-11-19 S D 5,142 $230.12 301,168 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F5) Transaction executed in multiple trades at prices ranging from $229.69 to $230.68 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
5 Common Common Stock 2025-11-19 S D 820 $230.78 300,348 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F6) Transaction executed in multiple trades at prices ranging from $230.71 to $230.85 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
6 Derivative Stock Option Grant 2025-11-19 M D 8,200 $0.00 16,437 D $34.19 · — to 2026-08-09 8,200 Common Stock (F7) The options vest 1/3 on each of August 9, 2020, 2021 and 2022.